Alpha 2.0
Login Register
» Authors » F Giannotti

F Giannotti

Explore the profile of F Giannotti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 658
Followers 0
Related Specialties
Neurology
General Surgery
Oncology
Top 10 Co-Authors
F Cortesi
S OTTAVIANO
O Bruni
A Ruggeri
A Tolino
V DAnto
E Gluckman
G Battipaglia
M Mohty
V Guidetti
Published In
Neurophysiol Clin
Bone Marrow Transplant
Leukemia
J Fr Ophtalmol
Funct Neurol
Affiliations
Soon will be listed here.
Recent Articles
1.
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients
Pradier A, Mamez A, Stephan C, Giannotti F, Masouridi-Levrat S, Wang S, et al.
Ann Oncol . 2022 Sep; 33(12):1333-1335. PMID: 36116692
No abstract available.
2.
Simultaneous intraocular and orbital involvement of NK/T-cell lymphoma
Kecik M, Prodhom S, Giannotti F, Thumann G, Malcles A
J Fr Ophtalmol . 2021 Jul; 44(10):e595-e596. PMID: 34274159
No abstract available.
3.
Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study
Lehrer J, Brissot E, Ruggeri A, Dulery R, Vekhoff A, Battipaglia G, et al.
Bone Marrow Transplant . 2017 Nov; 53(2):231-233. PMID: 29155420
No abstract available.
4.
Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis
Ustun C, Giannotti F, Zhang M, Wang H, Brunstein C, Labopin M, et al.
Leukemia . 2017 Jan; 31(6):1408-1414. PMID: 28119528
Allogeneic hematopoietic cell transplantation (HCT) from siblings or unrelated donors (URD) during complete remission (CR) may improve leukemia-free survival (LFS) in FMS-like tyrosine kinase 3+ (FLT3+) acute myeloid leukemia (AML),...
5.
Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification
Michel G, Cunha R, Ruggeri A, OBrien T, Bittencourt H, Dalle J, et al.
Leukemia . 2015 Sep; 30(5):1180-3. PMID: 26369981
No abstract available.
6.
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation
Battipaglia G, Ruggeri A, Brissot E, Mamez A, Malard F, Belhocine R, et al.
Bone Marrow Transplant . 2015 Aug; 50(12):1574-7. PMID: 26281029
No abstract available.
7.
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network
Marchesi F, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini R, et al.
Transpl Infect Dis . 2013 Nov; 16(1):158-64. PMID: 24215479
The incidence of cytomegalovirus (CMV) reactivations in patients with multiple myeloma (MM) receiving autologous stem cell transplantation (ASCT) is relatively low. However, the recent increased use of novel agents, such...
8.
Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center
Vecchio S, Chechi T, Giuliani G, Lilli A, Consoli L, Spaziani G, et al.
Minerva Cardioangiol . 2008 Jul; 56(4):391-9. PMID: 18614983
Aim: Percutaneous coronary interventions are increasingly applied to high-risk patients. The availability of hemodynamic support devices offers a promising option to prevent and treat low-output syndrome in these patients. The...
9.
An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism
Giannotti F, Cortesi F, Cerquiglini A, Bernabei P
J Autism Dev Disord . 2006 Aug; 36(6):741-52. PMID: 16897403
Long-term effectiveness of controlled-release melatonin in 25 children, aged 2.6-9.6 years with autism without other coexistent pathologies was evaluated openly. Sleep patterns were studied using Children's Sleep Habits Questionnaire (CSHQ)...
10.
Markers of hypercoagulability and inflammation predict mortality in patients with heart failure
Marcucci R, Gori A, Giannotti F, Baldi M, Verdiani V, Del Pace S, et al.
J Thromb Haemost . 2006 May; 4(5):1017-22. PMID: 16689753
Background And Aims: Plasma levels of inflammatory markers are increased in chronic heart failure (HF) and are also subclinical indicators of future HF. Inflammation is strictly correlated with clotting activation,...